Results 251 to 260 of about 2,491,737 (277)

Factors Associated With Successful Withdrawal of Biologic Agents in Children With Colchicine-Resistant Familial Mediterranean Fever

Journal of clinical rheumatology
Background Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disease, and colchicine is the mainstay of treatment. Approximately 5%–10% of patients may respond inadequately to colchicine, and anti–interleukin-1 (anti-IL-1) agents are ...
Özen Taş, Fatma Aydın, Müge Sezer, Banu Çelikel Acar, Onur Bahçeci, N. Çakar, E. Dumlupınar, Z. Özçakar   +7 more
semanticscholar   +1 more source

Nghiên cứu khâu mạch quang hóa của hệ khâu mạch quang trên cơ sở nhựa epoxy biến tính dầu trẩu. IV - Nghiên cứu khâu mạch quang hóa của hệ khâu mạch quang ETT 39-HDDA-I.184-TAS

, 2012
Lê Xuân Hiền, Vũ Minh Hoàng, Nguyễn Thị Việt Triều   +2 more
openalex   +1 more source

Green micro total analysis systems (GμTAS) for environmental samples

Trends in Environmental Analytical Chemistry, 2021
Chaudhery Mustansar Hussain, Rustem Kecili   +1 more
exaly  

Onset of neutropenia as an indicator of treatment response in the phase 3 RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo in patients with metastatic colorectal cancer.

, 2017
A. Ohtsu, T. Yoshino, A. Falcone, R. García-Carbonero, G. Argilés, A. Sobrero, M. Peeters, L. Makris, F. Benedetti, A. Zaniboni, Y. Shimada, K. Yamazaki, Y. Komatsu, H. Hochster, H. Lenz, B. Tran, Kenichiro Yoshida, E. Van Cutsem, R. Mayer   +18 more
semanticscholar   +1 more source

Novel hydrothermal synthesis of Mn-TaS3@rGO nanocomposite as a superior multifunctional mediator for advanced Li-S batteries

Journal of Colloid and Interface Science, 2023
Mohammed A Al-Tahan, Jianmin Zhang, Yutao Dong   +2 more
exaly  

特別講演 KUR-TASとともに30有余年--中性子回折による磁性研究 (京都大学原子炉実験所第39回学術講演会 報文集)

, 2005
眞治 川野
openalex  

A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Frontiers in Oncology, 2021
Zheling Chen
exaly  

TAS-102, a novel antitumor agent: A review of the mechanism of action

Cancer Treatment Reviews, 2015
Fotios Loupakis, Sebastian Stintzing
exaly  

Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study

International Journal of Clinical Oncology, 2020
Yoichirô Yoshida, Hiroshi Yoshida
exaly